Table 3.

Covariate analysis of total cholesterol (TC), HDL-cholesterol (HDL), TC/HDL ratio, LDL-cholesterol (LDL), tryglicerides (TG) and Framingham risk score (FRS), according to confounding factors used in the multivariable analysis: all confounders and treatment groups were included at the same time

	TC	HDL	TC/HDL	LDL	TG	FRS
Age (b-value, by 1)	0.3 p = 0.09	0.0 P = 0.92	0.0 P = 0.45	0.27 P = 0.10	0.1 P = 0.89	–
Sex (b-value, F vs M)	6.6 P = 0.10	3.4 P = 0.007	−0.24 P = 0.07	1.7 P = 0.65	2.8 P = 0.77	–
Diabetes (b-value, Y vs N)	−9.7 P = 0.22	0.9 P = 0.68	−0.3 P = 0.24	−7.4 P = 0.34	14.5 P = 0.43	–
Statins (b-value, Y vs N)	−10.1 P = 0.08	−1.3 P = 0.41	−0.0 P = 0.66	−7.8 P = 0.15	1.1 P = 0.93	−0.35 0.62
ART duration (b-value, by 1)	−0.2 P = 0.34	−0.1 P = 0.37	− 0.0 P = 0.86	−0.0 P = 0.84	− 0.4 P = 0.52	0.02 P = 0.58
Baseline value (b-value, by 1)	− 0.4 P < 0.0001	−0.3 P < 0.0001	− 0.43 P < 0.0001	−0.43 P < 0.0001	− 0.5 p < 0.0001	−0.02 P = 0.32

F female, M male, Y yes, N no, ART antiretroviral therapy